637 related articles for article (PubMed ID: 16527226)
1. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Chen SD; Sundaram V; Lochhead J; Patel CK
Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226
[TBL] [Abstract][Full Text] [Related]
2. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
4. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.
Er H
Am J Ophthalmol; 2006 Oct; 142(4):710; author reply 710. PubMed ID: 17011888
[No Abstract] [Full Text] [Related]
8. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
9. Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
Kawaji T; Takano A; Inomata Y; Sagara N; Iwao K; Inatani M; Fukushima M; Tanihara H
Br J Ophthalmol; 2008 Jan; 92(1):81-3. PubMed ID: 17965103
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
Williamson TH; O'Donnell A
Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
[TBL] [Abstract][Full Text] [Related]
11. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.
Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G
Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion.
Cheng KC; Wu WC
Kaohsiung J Med Sci; 2006 Jul; 22(7):321-30. PubMed ID: 16849100
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
16. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results.
Ramchandran RS; Fekrat S; Stinnett SS; Jaffe GJ
Am J Ophthalmol; 2008 Aug; 146(2):285-291. PubMed ID: 18533125
[TBL] [Abstract][Full Text] [Related]
17. Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion.
Ozdek S; Deren YT; Gurelik G; Hasanreisoglu B
Ophthalmic Res; 2008; 40(1):26-31. PubMed ID: 18025838
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
19. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
Hirano Y; Sakurai E; Yoshida M; Ogura Y
Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
